Understanding how stress responses in pancreatic cells affect early type 1 diabetes
The Integrated Stress Response in Human Islets During Early T1D
This study is looking at how stress in pancreatic cells affects the early stages of type 1 diabetes, with the goal of finding ways to help these cells stay strong and healthy as the disease develops.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-10653122 on NIH RePORTER |
What this research studies
This research investigates the role of stress responses in pancreatic islet cells during the early stages of type 1 diabetes (T1D). It aims to identify how inflammation triggers intracellular signaling pathways that may lead to the production of proteins that worsen autoimmune responses against these cells. By focusing on the integrated stress response, the study seeks to understand how these pathways can be targeted to improve cell resilience as T1D progresses. The research employs a multidisciplinary approach to explore these mechanisms in human islets.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk for or in the early stages of type 1 diabetes.
Not a fit: Patients with established type 1 diabetes or those without any risk factors for the disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preserving pancreatic cell function and delaying or preventing the onset of type 1 diabetes.
How similar studies have performed: Other research has shown promise in targeting stress responses in cells, suggesting that this approach could lead to meaningful advancements in understanding and treating type 1 diabetes.
Where this research is happening
Chicago, United States
- University of Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Mirmira, Raghavendra G — University of Chicago
- Study coordinator: Mirmira, Raghavendra G
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.